| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0006826> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0016441> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0020966> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0020967> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0023517> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0027651> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0086692> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0135710> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C0965245> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C1155229> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C1321301> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C1817908> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C2986635> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C3203086> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C4086713> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C4684977> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5392067> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5392068> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5392069> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5392807> <https://research.tib.eu/covid-19/entity/34973510_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: a.lasagna@smatteo.pv.it.\', \'Molecular Virology Unit, Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Microbiology Unit, Hospital Guglielmo da Saliceto, Piacenza, Italy.\', \'Oncology Unit, Hospital Guglielmo da Saliceto, Piacenza, Italy.\', \'Molecular Virology Unit, Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Departments of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.\', \'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Agustoni_F> <https://research.tib.eu/covid-19/entity/Alessio_N> <https://research.tib.eu/covid-19/entity/Arena_F> <https://research.tib.eu/covid-19/entity/Baldanti_F> <https://research.tib.eu/covid-19/entity/Bergami_F> <https://research.tib.eu/covid-19/entity/Borgetto_S> <https://research.tib.eu/covid-19/entity/Cassaniti_I> <https://research.tib.eu/covid-19/entity/Cavanna_L> <https://research.tib.eu/covid-19/entity/Comolli_G> <https://research.tib.eu/covid-19/entity/Falzoni_M> <https://research.tib.eu/covid-19/entity/Ferrari_A> <https://research.tib.eu/covid-19/entity/Lasagna_A> <https://research.tib.eu/covid-19/entity/Lilleri_D> <https://research.tib.eu/covid-19/entity/Lo_Cascio_G> <https://research.tib.eu/covid-19/entity/Pedrazzoli_P> <https://research.tib.eu/covid-19/entity/Percivalle_E> <https://research.tib.eu/covid-19/entity/Sammartino_J_C> <https://research.tib.eu/covid-19/entity/Sarasini_A> <https://research.tib.eu/covid-19/entity/Schiavo_R> <https://research.tib.eu/covid-19/entity/Secondino_S> <https://research.tib.eu/covid-19/entity/Zavaglio_F>
?:doi	S2059-7029(21)00321-510.1016/j.esmoop.2021.100359
?:doi	<https://research.tib.eu/covid-19/entity/S2059-7029%2821%2900321-510.1016/j.esmoop.2021.100359>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	ESMO open
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34973510>
?:pmid	<https://research.tib.eu/covid-19/entity/34973510>
?:pmid	34973510
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1318468_PROCESS_OF_C1516213>
?:title	Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: a.lasagna@smatteo.pv.it.\', \'Molecular Virology Unit, Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Microbiology Unit, Hospital Guglielmo da Saliceto, Piacenza, Italy.\', \'Oncology Unit, Hospital Guglielmo da Saliceto, Piacenza, Italy.\', \'Molecular Virology Unit, Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Departments of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.\', \'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.\']

?:citedBy

-1

?:creator

?:doi

S2059-7029(21)00321-510.1016/j.esmoop.2021.100359

?:doi

<https://research.tib.eu/covid-19/entity/S2059-7029%2821%2900321-510.1016/j.esmoop.2021.100359>

?:hasPublicationType

?:journal

ESMO open

is ?:pmid of

<https://research.tib.eu/covid-19/entity/34973510>

?:pmid

<https://research.tib.eu/covid-19/entity/34973510>

?:pmid

34973510

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

-1.0

?:rankingScore_hIndex

-1

is ?:relation_isRelatedTo_publication of

<https://research.tib.eu/covid-19/entity/C1318468_PROCESS_OF_C1516213>

?:title

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up.

?:type

?:year

2022

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34973510>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34973510>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata